Hebert, Adelaide, Debbie Glaab, and Rhonda Schreiber. “A Phase 1 Open -Label Multicenter Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Calcipotriene Foam, 0.005% Applied Under Maximal Use Conditions in Adolescent Subjects With Plaque Psoriasis”. SKIN The Journal of Cutaneous Medicine 3, no. 2 (March 11, 2019): 171. Accessed July 22, 2024. https://jofskin.org/index.php/skin/article/view/528.